147 related articles for article (PubMed ID: 32439211)
1. Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?
Di Noia V; D'Aveni A; Squadroni M; Beretta GD; Ceresoli GL
Lung Cancer; 2020 Jul; 145():208-210. PubMed ID: 32439211
[No Abstract] [Full Text] [Related]
2. Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic.
Chang HL; Wei PJ; Wu KL; Huang HL; Yang CJ
Lung Cancer; 2020 Aug; 146():376-377. PubMed ID: 32576385
[No Abstract] [Full Text] [Related]
3. Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience.
Rossi D
Lung Cancer; 2020 Jul; 145():83-84. PubMed ID: 32416433
[TBL] [Abstract][Full Text] [Related]
4. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection?
Sereno M; Gutiérrez-Gutiérrez G; Sandoval C; Falagan S; Jimenez-Gordo AM; Merino M; López-Menchaca R; Martínez-Martin P; Roa S; Casado E
Lung Cancer; 2020 Jul; 145():213-215. PubMed ID: 32389426
[No Abstract] [Full Text] [Related]
5. Blood vessel injury may spur disease's fatal second phase.
Matacic C
Science; 2020 Jun; 368(6495):1039-1040. PubMed ID: 32499417
[No Abstract] [Full Text] [Related]
6. Treatment and Outcome of a Patient With Lung Cancer Infected With Severe Acute Respiratory Syndrome Coronavirus-2.
Zhang H; Xie C; Huang Y
J Thorac Oncol; 2020 May; 15(5):e63-e64. PubMed ID: 32147577
[No Abstract] [Full Text] [Related]
7. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
Yekedüz E; Dursun B; Aydın GÇ; Yazgan SC; Öztürk HH; Azap A; Utkan G; Ürün Y
J Oncol Pharm Pract; 2020 Jul; 26(5):1289-1294. PubMed ID: 32423324
[TBL] [Abstract][Full Text] [Related]
8. Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
[No Abstract] [Full Text] [Related]
10. COVID-19: the use of immunotherapy in metastatic lung cancer.
Davis AP; Boyer M; Lee JH; Kao SC
Immunotherapy; 2020 Jun; 12(8):545-548. PubMed ID: 32349579
[No Abstract] [Full Text] [Related]
11. The Enemy Within: Sudden-Onset Reversible Cardiogenic Shock With Biopsy-Proven Cardiac Myocyte Infection by Severe Acute Respiratory Syndrome Coronavirus 2.
Albert CL; Carmona-Rubio AE; Weiss AJ; Procop GG; Starling RC; Rodriguez ER
Circulation; 2020 Nov; 142(19):1865-1870. PubMed ID: 32997947
[No Abstract] [Full Text] [Related]
12. COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!
Lazzerini PE; Boutjdir M; Capecchi PL
Circulation; 2020 Jul; 142(1):7-9. PubMed ID: 32286863
[No Abstract] [Full Text] [Related]
13. Two Sorts of Microthrombi in a Patient With Coronavirus Disease 2019 and Lung Cancer.
Calabrese F; Fortarezza F; Giraudo C; Pezzuto F; Faccioli E; Rea F; Pittarello D; Correale C; Navalesi P
J Thorac Oncol; 2020 Nov; 15(11):1782-1785. PubMed ID: 32866652
[No Abstract] [Full Text] [Related]
14. Challenges in lung cancer therapy during the COVID-19 pandemic.
Calabrò L; Peters S; Soria JC; Di Giacomo AM; Barlesi F; Covre A; Altomonte M; Vegni V; Gridelli C; Reck M; Rizvi N; Maio M
Lancet Respir Med; 2020 Jun; 8(6):542-544. PubMed ID: 32278368
[No Abstract] [Full Text] [Related]
15. The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2.
Wang K; Liu Y; Hu T; Liu Y; Liu C
Lung Cancer; 2020 Aug; 146():373-375. PubMed ID: 32563532
[No Abstract] [Full Text] [Related]
16. Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019.
Di Cosimo S; Malfettone A; Pérez-García JM; Llombart-Cussac A; Miceli R; Curigliano G; Cortés J
Eur J Cancer; 2020 Aug; 135():62-65. PubMed ID: 32544799
[TBL] [Abstract][Full Text] [Related]
17. Alert to Potential Contagiousness: A Case of Lung Cancer With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Ouyang W; Yu J; Zhang J; Xie C
J Thorac Oncol; 2020 Jun; 15(6):e82-e83. PubMed ID: 32305592
[No Abstract] [Full Text] [Related]
18. The Possible Protective Role of α-Synuclein Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients With Parkinson's Disease.
Ait Wahmane S; Achbani A; Ouhaz Z; Elatiqi M; Belmouden A; Nejmeddine M
Mov Disord; 2020 Aug; 35(8):1293-1294. PubMed ID: 32519352
[No Abstract] [Full Text] [Related]
19. Consideration of Pannexin 1 channels in COVID-19 pathology and treatment.
Swayne LA; Johnstone SR; Ng CS; Sanchez-Arias JC; Good ME; Penuela S; Lohman AW; Wolpe AG; Laubach VE; Koval M; Isakson BE
Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L121-L125. PubMed ID: 32519892
[No Abstract] [Full Text] [Related]
20. Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs.
Conti A; Lasagni C; Bigi L; Pellacani G
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e360-e361. PubMed ID: 32379913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
